At a Glance
| Detail | Ex Parte | OmniLex |
|---|---|---|
| Category | Research & Analytics | Research & Analytics |
| Total raised | $7.5M | $4.5M |
| Rounds tracked | 1 | 1 |
| Latest round | Series A, $7.5M · Mar 2022 | Seed, $4.5M · Nov 2025 |
| Last valuation | Not disclosed | Not disclosed |
| Lead investors | R8 Capital, Ironbound Partners | Founderful |
| Built for | Not disclosed | Not disclosed |
| Headquarters | US | Switzerland |
Funding, Side by Side
Ex Parte rounds
- Mar 2022Series A$7.5M
OmniLex rounds
- Nov 2025Seed$4.5M
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, Ex Parte or OmniLex?
- Ex Parte has raised $7.5M in disclosed funding, compared with $4.5M for OmniLex.
- Do Ex Parte and OmniLex share investors?
- No. None of the investors we track have backed both companies.
- What is Ex Parte best for?
- Litigation intelligence for patent and complex disputes.
Source: Legal Tech Circle funding data, from public announcements. Updated November 12, 2026.